Table 1.
Chronic hepatitis B (CHB) patient characteristics for the non-nonalcoholic fatty liver disease (NAFLD) and NAFLD groups.
| Characteristic | CHB with component of MetS |
||
|---|---|---|---|
| Non-NAFLD group | NAFLD group | p Value | |
| Sample size, n | 1087 | 149 | – |
| Sex (male), n (%) | 773 (71.1) | 116 (78.4) | 0.065 |
| Age (years) | 43.04 ± 12.18 | 40.49 ± 12.29 | 0.018 |
| Smoking, n (%) | 286 (26.3) | 42 (28.4) | 0.593 |
| Alcohol consumption, n (%) | 234 (21.5) | 50 (33.8) | 0.001 |
| T2DM, n (%) | 145 (13.3) | 21 (14.2) | 0.776 |
| Metabolic syndrome, n (%) | 115 (10.6) | 30 (20.3) | 0.001 |
| Weight, kg | 63.47 ± 11.15 | 80.21 ± 17.25 | < 0.001 |
| Height, cm | 165.35 ± 8.54 | 168.14 ± 7.32 | <0.001 |
| SBP, mm Hg | 126.92 ± 13.29 | 132.24 ± 13.28 | <0.001 |
| DBP, mm Hg | 81.21 ± 9.22 | 85.89 ± 9.88 | <0.001 |
| Waist circumference, cm | 80.06 ± 10.26 | 92.29 ± 8.75 | <0.001 |
| Hip circumference, cm | 91.10 ± 6.86 | 97.91 ± 7.23 | <0.001 |
| Liver stiffness, Kpa | 8.77 ± 9.51 | 7.75 ± 5.83 | 0.206 |
| PLT, 109/l | 242.72 ± 58.92 | 245.72 ± 62.47 | 0.567 |
| ALT, U/l | 91.12 ± 51.35 | 87.86 ± 42.42 | 0.473 |
| AST, U/l | 59.79 ± 35.67 | 61.03 ± 20.76 | 0.685 |
| GGT, U/l | 62.21 ± 34.07 | 72.81 ± 36.01 | 0.001 |
| Total cholesterol, mmol/l | 5.08 ± 0.75 | 5.22 ± 0.72 | 0.039 |
| HDL-cholesterol, mmol/l | 1.32 ± 0.31 | 1.31 ± 0.30 | 0.994 |
| LDL-cholesterol, mmol/l | 2.99 ± 0.69 | 3.19 ± 0.66 | 0.001 |
| Triglycerides, mmol/l | 1.38 ± 0.49 | 1.56 ± 0.52 | <0.001 |
| Uric acid, mmol/l | 413.36 ± 96.47 | 459.06 ± 123.11 | < 0.001 |
| HBV DNA, log10 IU/ml | 0.98 ± 1.72 | 0.97 ± 1.71 | 0.987 |
| HBeAg ( + ), n (%) | 630 (58.0) | 90 (60.4) | 0.570 |
ALT: serum aspartate aminotransferase; AST: alanine aminotransferase; DBP: diastolic blood pressure; GGT: gamma-glutamyltransferase; HBeAg: hepatitis B e antigen; HBV: hepatitis B virus; HDL: high density lipoprotein; LDL: low density lipoprotein; MetS: metabolic syndrome; PLT: platelet; SBP: systolic blood pressure; T2DM: type 2 diabetes mellitus.